Lv1
70 积分 2022-05-10 加入
The Lancet Breast Cancer Commission
3个月前
已完结
Comprehensive profiling of BRCA1 and BRCA2 variants in breast and ovarian cancer in Chinese patients
5个月前
已完结
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
5个月前
已完结
A review of prognostic and predictive biomarkers in breast cancer
5个月前
已完结
Updates on breast biomarkers
5个月前
已完结
Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA)
5个月前
已完结
The impact of initial tumor response on survival outcomes of patients with HER2-positive advanced breast cancer treated with docetaxel, trastuzumab, and pertuzumab: an exploratory analysis of the CLEOPATRA trial
7个月前
已完结
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
7个月前
已完结
Datopotamab Deruxtecan, a Novel TROP2-directed Antibody–drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells
9个月前
已完结
Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads
9个月前
已完结
Genomic architecture of heterosis for yield traits in rice
皖公网安备34019202002308
